T. Mori et al. / Tetrahedron Letters 46 (2005) 6417–6422
6421
Acknowledgements
We thank Drs. Takashiro Akitsu and Masaru Yao
(Keio University) for X-ray crystallographic analysis.
This research was partially supported by a Grant-in-
Aid for the 21st Century COE program ꢃKEIO Life
Conjugate Chemistryꢂ from the Ministry of Education,
Culture, Sports, Science and Technology, Japan and a
Grant-in-Aid for Scientific Research on Priority Areas
(A) ꢃExploitation of Multi-Element Cyclic Moleculesꢂ
from the Ministry of Education, Culture, Sports, Sci-
ence and Technology, Japan.
Figure 2. X-ray crystal structure of 21.
References and notes
1. Higashibayashi, S.; Hashimoto, K.; Nakata, M. Tetra-
hedron Lett. 2002, 43, 105–110.
O
O
N
O
O
2. Higashibayashi, S.; Mori, T.; Shinko, K.; Hashimoto, K.;
Nakata, M. Heterocycles 2002, 57, 111–122.
3. Higashibayashi, S.; Kohno, M.; Goto, T.; Suzuki, K.;
Mori, T.; Hashimoto, K.; Nakata, M. Tetrahedron Lett.
2004, 45, 3707–3712.
N
a,b
MeO
MeO
Br
HO
H
TBSO
H
4. The thiostrepton family of peptide antibiotics, see Refs. 1
and 2.
10
22
5. Synthetic studies on the thiostrepton family of peptide
antibiotics, see: (a) Shin, C.; Ito, A.; Okumura, K.;
Nakamura, Y. Chem. Lett. 1995, 45–46; (b) Nicolaou,
c,d
O
O
´
K. C.; Safina, B. S.; Funke, C.; Zak, M.; Zecri, F. J.
N
t-BuO
Angew. Chem., Int. Ed. 2002, 41, 1937–1940; (c) Nicolaou,
K. C.; Nevalainen, M.; Safina, B. S.; Zak, M.; Bulat, S.
Angew. Chem., Int. Ed. 2002, 41, 1941–1945; (d) Nicolaou,
K. C.; Nevalainen, M.; Zak, M.; Bulat, S.; Bella, M.;
Safina, B. S. Angew. Chem., Int. Ed. 2003, 42, 3418–3424;
(e) Nicolaou, K. C.; Safina, B. S.; Zak, M.; Estrada, A. A.;
Lee, S. H. Angew. Chem., Int. Ed. 2004, 43, 5087–5092; (f)
Nicolaou, K. C.; Zak, M.; Safina, B. S.; Lee, S. H.;
Estrada, A. A. Angew. Chem., Int. Ed. 2004, 43, 5092–
5097.
TBSO
H
4
Scheme 7. Synthesis of the dihydroquinoline segment 4. Reagents and
conditions: (a) TBSOTf (1.2 equiv), 2,6-lutidine (2.0 equiv), CH2Cl2,
0 ꢁC, 0.5 h, 82%; (b) DBU (3.5 equiv), THF, rt, 1h, 95%; (c) TMSOK
(1.0 equiv), Et2O, 0 ꢁC, 0.5 h; (d) Boc2O (2.0 equiv), DMAP (0.3 equiv),
t-BuOH, rt, 3 h, 86% (two steps). TBS = tert-butyldimethylsilyl,
TMS = trimethylsilyl, Boc = tert-butoxycarbonyl, DMAP = 4-(di-
methylamino)pyridine.
6. Recently, a total synthesis of thiostrepton has appeared;
see Refs. 5e and 5f.
7. Mori, T.; Tohmiya, H.; Satouchi, Y.; Higashibayashi, S.;
Hashimoto, K.; Nakata, M, see following letter, Tetra-
28
8. ½aꢁD ꢀ76.3 (c 1.00, EtOH) [lit.9 ½aꢁD ꢀ78 (c 1.6,
we could obtain sufficient amounts of the hydroxyethyl-
bearing dihydroquinoline substructure.
20
EtOH), lit.10 ½aꢁD ꢀ79 (c 1, EtOH)].
9. Bodanszky, M.; Fried, J.; Sheehan, J. T.; Williams, N. J.;
Alicino, J.; Cohen, A. I.; Keeler, B. T.; Birkhimer, C. A.
J. Am. Chem. Soc. 1964, 86, 2478–2490.
After silylation (82%) of 10, the resulting silyl ether was
subjected to dehydrobromination with DBU to afford
22 in 95% yield (Scheme 7). Methyl ester 22 was trans-
formed into the desired dihydroquinoline segment 4 by
deprotection with TMSOK22 followed by re-esterifica-
tion with Boc2O23 in 86% yield.
10. Ebata, M.; Miyazaki, K.; Otsuka, H. J. Antibiot. 1969, 22,
423–433.
11. Priestley, N. D.; Smith, T. M.; Shipley, P. R.; Floss, H. G.
Bioorg. Med. Chem. 1996, 4, 1135–1147.
12. (a) Kobayashi, G.; Furukawa, S. Pharm. Bull. 1953, 1,
347–349; (b) Boekelheide, V.; Linn, W. J. J. Am. Chem.
Soc. 1954, 76, 1286–1291; (c) Koenig, T. J. Am. Chem.
Soc. 1966, 88, 4045–4049; (d) Korytnyk, W.; Srivastava, S.
C.; Angelino, N.; Potti, P. G. G.; Paul, B. J. Med. Chem.
1973, 16, 1096–1101; (e) Konno, K.; Hashimoto, K.;
Shirahama, H.; Matsumoto, T. Heterocycles 1986, 24,
2169–2172; (f) Fontenas, C.; Bejan, E.; Haddou, H. A.;
Balavoine, G. G. A. Synth. Commun. 1995, 25, 629–
633.
In summary, we have synthesized the dihydroquinoline
segment 4 of thiostrepton, the siomycins, and the thio-
peptins. The key reactions are the one-pot olefination
via the Matsumura–Boekelheide rearrangement using
Tf2O and triethylamine and the stereoselective addition
reaction controlled by the stereocenter of the peri-posi-
tion. In the following letter,7 we will describe the synthe-
sis of the siomycin cyclic core portion containing the
dehydropiperidine, dihydroquinoline (i.e., 4), L-valine,
and masked dehydroalanine (i.e., b-phenylselenoala-
nine) segments.
13. It has been reported that 2-picoline N-oxide was trans-
formed with tosyl chloride into 2-chloromethylpyridine
via 2-tosyloxymethylpyridine, see: Matsumura, E. Nippon
Kagaku Kaishi 1953, 74, 363–364.